4.8 Review

Chemokines in the Immunopathogenesis of Hepatitis C Infection

Journal

HEPATOLOGY
Volume 49, Issue 2, Pages 676-688

Publisher

WILEY
DOI: 10.1002/hep.22763

Keywords

-

Funding

  1. Wellcome Trust
  2. European Commission [QLGI-CT-1999-00295]
  3. Medical Research Council [G0300101]
  4. National Institutes of Health [5RO1AA014257]
  5. MRC [G0300101, G0700301, G0400496] Funding Source: UKRI
  6. Medical Research Council [G0700301, G9818340B, G0400496, G0300101] Funding Source: researchfish

Ask authors/readers for more resources

Chronic infection with the hepatitis C virus, a noncytopathic hepatotropic RNA virus, affects over 170 million people worldwide. In the majority of cases, neither the early innate immune response nor the later adaptive immune response succeeds in clearing the virus, and the infection becomes chronic. Furthermore, in many patients, the ineffective inflammatory response drives fibrogenesis and the development of cirrhosis. It is critical to understand this immune pathology if preventative and curative therapies are to be developed. Chemokines are a superfamily of small proteins that promote leukocyte migration and orchestrate the immune response to viruses, including hepatitis C virus. Chemokines are crucial for viral elimination, but inappropriate persistence of expression in chronic hepatitis C infection can drive tissue damage and inflammation. Here we review the role of chemokines and their receptors in hepatitis C virus infection. (HEPATOLOGY 2009;49:676-688.)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available